Positive prostate biopsy rate consistently increases with age at the same prostate-specific antigen level in patients with normal digital rectal examination

Urology

Volumn 51, Issue 4, 1998, Pages 531-533

  Orozco, Roberto ^b   Kunnel, Binitha ^b   O'Dowd, Gerard J ^a   Stamey, Thomas A ^b  

^a UroCor Incorporated   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

ADULT; AGE; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER SCREENING; CLINICAL EXAMINATION; CLINICAL TRIAL; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC VALUE; DISEASE MARKER; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE BIOPSY; PROSTATE CANCER; REFERENCE VALUE;

ADENOCARCINOMA; AGE FACTORS; AGED; HUMANS; MALE; MIDDLE AGED; PALPATION; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RECTUM;

EID: 0031897774     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(98)00003-X     Document Type: Article

References (10)

1. Oesterling JE, Jacobsen SJ, Chute CG, Huess HA, Girman CJ, Panser LA, and Lieber MM: Serum prostate-specific antigen in a community-based population of healthy men: establishment of age-specific reference ranges. JAMA 270: 860-864, 1993.
2. Catalona WJ, Richie JP, Ahman FR, Hudson MA, Scardino PT, Flanagan RC, de Kernion JB, Ratliff TL, Kavoussi LR, Dalkin BL, et al: Comparison of digital rectal examination and serum prostate antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J Urol 151: 1283-1290, 1994.
3. Hammerer PG, McNeal JE, and Stamey TA: Correlation between serum PSA levels and the volume of the individual glandular zones of the human prostate. J Urol 153: 111-114, 1995.
4. Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, and Redwine EA: Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 317: 909-916, 1993.
5. Babaian J, Kojima M, Ramirez EI, and Johnston D: Comparative analysis of prostate specific antigen and its indexes in the detection of prostate cancer. J Urol 156: 432-437, 1996.
6. Hammerer P, and Huland H: Systematic sextant biopsies in 651 patients referred for prostate evaluation. J Urol 151: 99-102, 1994.
7. Stamey TA: Editorial comment. J Urol 158: 1434-1435, 1997.
8. Schmid HP, McNeal JE, and Stamey TA: Observations on the doubling time of prostate cancer: the use of serial prostate specific antigen in patients with untreated disease as a measure of increasing cancer volume. Cancer 71: 2031-2040, 1993.
9. Whittemore AS, Lele C, Friedman GD, Stamey TA, Vogelman JH, and Orentreich N: Prostate-specific antigen as a predictor of prostate cancer in black and white men. J Natl Cancer Inst 87: 354-360, 1995.
10. Noldus J, and Stamey TA: Limitations of serum PSA in predicting peripheral and transition zone cancer volume as measured by correlation coefficients. J Urol 155: 232-237, 1996.